Pro Share Advisors LLC Heron Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 22,183 shares of HRTX stock, worth $23,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,183

Previous 13,869 59.95%

Holding current value

$23,735

Previous $48,000 8.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.73 - $3.67 $14,383 - $30,512	8,314 Added 59.95%	22,183 $44,000
Q2 2024 Aug 13, 2024	SELL	$2.32 - $3.86 $10,985 - $18,277	-4,735 Reduced 25.45%	13,869 $48,000
Q1 2024 May 08, 2024	BUY	$1.71 - $3.06 $2,506 - $4,485	1,466 Added 8.55%	18,604 $51,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $1,989 - $6,706	3,685 Added 27.39%	17,138 $29,000
Q3 2023 Nov 13, 2023	SELL	$0.97 - $1.8 $13 - $25	-14 Reduced 0.1%	13,453 $13,000
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.88 $1,504 - $3,902	1,355 Added 11.19%	13,467 $15,000
Q1 2023 May 11, 2023	SELL	$1.51 - $3.25 $1,706 - $3,672	-1,130 Reduced 8.53%	12,112 $18,000
Q4 2022 Feb 02, 2023	BUY	$2.25 - $4.67 $4,270 - $8,863	1,898 Added 16.73%	13,242 $33,000
Q3 2022 Nov 04, 2022	SELL	$2.66 - $5.37 $579 - $1,170	-218 Reduced 1.89%	11,344 $48,000
Q2 2022 Aug 01, 2022	SELL	$2.3 - $6.29 $13,252 - $36,242	-5,762 Reduced 33.26%	11,562 $32,000
Q1 2022 May 10, 2022	SELL	$4.63 - $9.94 $13,065 - $28,050	-2,822 Reduced 14.01%	17,324 $99,000
Q4 2021 Feb 08, 2022	BUY	$8.35 - $12.6 $69,371 - $104,680	8,308 Added 70.18%	20,146 $184,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $122,876 - $181,950	-12,130 Reduced 50.61%	11,838 $127,000
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $7,311 - $10,182	551 Added 2.35%	23,968 $372,000
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $57,988 - $82,921	4,002 Added 20.61%	23,417 $380,000
Q4 2020 Feb 09, 2021	BUY	$14.61 - $22.14 $126,712 - $192,020	8,673 Added 80.74%	19,415 $411,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $15,966 - $20,755	-1,168 Reduced 9.81%	10,742 $159,000
Q2 2020 Aug 03, 2020	BUY	$10.89 - $21.47 $129,699 - $255,707	11,910 New	11,910 $175,000
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $116,570 - $279,861	-11,395 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $198,500 - $303,220	11,395 New	11,395 $268,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $185,756 - $269,908	-8,432 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $840 - $1,143	28 Added 0.33%	8,432 $267,000
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $221,865 - $352,968	8,404 New	8,404 $326,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Heron Therapeutics, Inc. Transaction History